Development and approval of quality standards for pharmaceutical substances of plant origin in the Russian Federation

Issues related to the creation of modern normative documentation specifying the quality of pharmaceutical substances of plant origin (medicinal plant material) are considered in this article. A brief historical background of the State Pharmacopoeia development is presented. With the help of a system research method and information-analytical method, a chart for the approval and inclusion of general pharmacopoeial monographs projects and pharmacopoeial monographs projects on medicinal plant materials in the State Pharmacopoeia of Russian Federation was developed and proposed taking into account Russian legislation. © 2018, Pharmainfo Publications. All rights reserved.

Авторы
Bokov D.O.1, 2 , Smyslova O.A.1 , Litvinova T.M.1 , Samylina I.A.1 , Potanina O.G. 3
Издательство
Pharmainfo Publications
Номер выпуска
7
Язык
Английский
Страницы
1818-1819
Статус
Опубликовано
Том
10
Год
2018
Организации
  • 1 Sechenov First Moscow State Medical University, Trubetskaya St., 8, bldg. 2, Moscow, 119991, Russian Federation
  • 2 Federal Research Center for Nutrition, Biotechnology and Food Safety, Ustyinsky pr., 2/14, Moscow, 109240, Russian Federation
  • 3 Рeoples’ Friendship University of Russia, RUDN University, Miklukho-Maklaya St., 6, Moscow, 117198, Russian Federation
Ключевые слова
General pharmacopoeial monographs; Medicinal plant material; Pharmaceutical substances of plant origin; Pharmacopoeial monographs; Quality of herbal drugs; State pharmacopoeia of Russian Federation
Цитировать
Поделиться

Другие записи